Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2014 3
2015 8
2016 12
2017 12
2018 21
2019 22
2020 32
2021 26
2022 23
2023 16
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

161 results

Results by year

Filters applied: . Clear all
Page 1
Consistency between Primary Uterine Corpus Malignancies and Their Corresponding Patient-Derived Xenograft Models.
Ueda S, Tanaka T, Hirosuna K, Miyamoto S, Murakami H, Nishie R, Tsuchihashi H, Toji A, Morita N, Hashida S, Daimon A, Terada S, Maruoka H, Kogata Y, Taniguchi K, Komura K, Ohmichi M. Ueda S, et al. Among authors: taniguchi k. Int J Mol Sci. 2024 Jan 25;25(3):1486. doi: 10.3390/ijms25031486. Int J Mol Sci. 2024. PMID: 38338763 Free PMC article.
Antitumor effects of chemically modified miR-143 lipoplexes in a mouse model of pelvic colorectal cancer via myristoylated alanine-rich C kinase substrate downregulation.
Arima J, Taniguchi K, Sugito N, Heishima K, Tokumaru Y, Inomata Y, Komura K, Tanaka T, Shibata MA, Lee SW, Akao Y. Arima J, et al. Among authors: taniguchi k. Mol Ther Nucleic Acids. 2023 Nov 15;34:102079. doi: 10.1016/j.omtn.2023.102079. eCollection 2023 Dec 12. Mol Ther Nucleic Acids. 2023. PMID: 38213952 Free PMC article.
The Impact of FGFR3 Alterations on the Tumor Microenvironment and the Efficacy of Immune Checkpoint Inhibitors in Bladder Cancer.
Komura K, Hirosuna K, Tokushige S, Tsujino T, Nishimura K, Ishida M, Hayashi T, Ura A, Ohno T, Yamazaki S, Nakamori K, Kinoshita S, Maenosono R, Ajiro M, Yoshikawa Y, Takai T, Tsutsumi T, Taniguchi K, Tanaka T, Takahara K, Konuma T, Inamoto T, Hirose Y, Ono F, Shiraishi Y, Yoshimi A, Azuma H. Komura K, et al. Among authors: taniguchi k. Mol Cancer. 2023 Nov 18;22(1):185. doi: 10.1186/s12943-023-01897-6. Mol Cancer. 2023. PMID: 37980528 Free PMC article.
Interdisciplinary electrosynthesis: general discussion.
Ackermann L, Avanthay M, Batanero B, Boucher DG, Broersen P, Carroll E, Flexer V, Francke R, Fuchigami T, Gerulskis R, Hickey DP, Hockin B, Kuhn A, Milner MJ, Minteer SD, Moeller K, Nguyen ZA, Nokami T, Rasul S, Shida N, Sokalu E, Taniguchi K, von Wolff N. Ackermann L, et al. Among authors: taniguchi k. Faraday Discuss. 2023 Oct 31;247(0):125-135. doi: 10.1039/d3fd90037a. Faraday Discuss. 2023. PMID: 37782222 No abstract available.
Tertiary lymphoid structure and neutrophil-lymphocyte ratio coordinately predict outcome of pembrolizumab.
Komura K, Tokushige S, Ishida M, Hirosuna K, Yamazaki S, Nishimura K, Ajiro M, Ohno T, Nakamori K, Kinoshita S, Tsujino T, Maenosono R, Yoshikawa Y, Takai T, Tsutsumi T, Taniguchi K, Tanaka T, Takahara K, Inamoto T, Hirose Y, Ono F, Shiraishi Y, Yoshimi A, Azuma H. Komura K, et al. Among authors: taniguchi k. Cancer Sci. 2023 Dec;114(12):4622-4631. doi: 10.1111/cas.15976. Epub 2023 Sep 26. Cancer Sci. 2023. PMID: 37752769 Free PMC article.
Intratumoral metabolic heterogeneity of colorectal cancer.
Hirose Y, Taniguchi K. Hirose Y, et al. Among authors: taniguchi k. Am J Physiol Cell Physiol. 2023 Oct 1;325(4):C1073-C1084. doi: 10.1152/ajpcell.00139.2021. Epub 2023 Sep 4. Am J Physiol Cell Physiol. 2023. PMID: 37661922 Review.
161 results